Abiopharma

New Form 6-K - Nyxoah SA Filed: 2025-07-29 AccNo: 0001104659-25-071343 Size: 35 KB

General Announcement: Press release

New Form 4 - Serina Therapeutics, Inc. Filed: 2025-07-29 AccNo: 0001708599-25-000078 Size: 8 KB

New Form 8-K - ImageneBio, Inc. Filed: 2025-07-29 AccNo: 0001193125-25-167089 Size: 16 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.02: Unregistered Sales of Equity Securities Item 3.03: Material Modifications to Rights of Security Holders Item 5.01: Changes in …

New Form 8-K - Serina Therapeutics, Inc. Filed: 2025-07-29 AccNo: 0001708599-25-000076 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form EFFECT - Can-Fite BioPharma Ltd. Filed: 2025-07-28 AccNo: 9999999995-25-002378 Size: 1 KB

New Form EFFECT - Predictive Oncology Inc. Filed: 2025-07-28 AccNo: 9999999995-25-002376 Size: 2 KB

New Form EFFECT - IGC Pharma, Inc. Filed: 2025-07-28 AccNo: 9999999995-25-002377 Size: 1 KB

New Form EFFECT - Innovative Eyewear Inc Filed: 2025-07-28 AccNo: 9999999995-25-002375 Size: 1 KB

New Form EFFECT - Venus Concept Inc. Filed: 2025-07-28 AccNo: 9999999995-25-002372 Size: 1 KB

New Form EFFECT - Elevation Oncology, Inc. Filed: 2025-07-28 AccNo: 9999999995-25-002367 Size: 1 KB

New Form EFFECT - Elevation Oncology, Inc. Filed: 2025-07-28 AccNo: 9999999995-25-002365 Size: 1 KB

New Form EFFECT - Verve Therapeutics, Inc. Filed: 2025-07-28 AccNo: 9999999995-25-002366 Size: 1 KB

New Form EFFECT - AIM ImmunoTech Inc. Filed: 2025-07-28 AccNo: 9999999995-25-002368 Size: 1 KB

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025